We had initially demonstrated that FAT1 is a major contributor to pro-tumorigenic inflammation in gliomas driving the upregulation of pro-inflammatory cytokines like IL6 and IL1ß and also COX2 via AP1 activation [17]. This evidence concerns the gene FAT1 and central nervous system cancer.